• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AsiDNA 对危机中端粒融合发生率的影响。

Effect of DNA repair inhibitor AsiDNA on the incidence of telomere fusion in crisis.

机构信息

Structure and Instability of Genomes laboratory, "Muséum National d'Histoire Naturelle" (MNHN), Inserm U1154, CNRS UMR 7196, Paris, France.

出版信息

Hum Mol Genet. 2021 Apr 26;30(3-4):172-181. doi: 10.1093/hmg/ddab008.

DOI:10.1093/hmg/ddab008
PMID:33480989
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8091035/
Abstract

Telomere fusions lead to a state of genomic instability, and are thought to drive clonal evolution and tumorigenesis. Telomere fusions occur via both Classical and Alternative Non-Homologous End Joining repair pathways. AsiDNA is a DNA repair inhibitor that acts by mimicking a DNA double strand break (DSB) and hijacking the recruitment of proteins involved in various DNA repair pathways. In this study, we investigated whether the inhibition of DSB-repair pathways by AsiDNA could prevent telomere fusions during crisis. The present study showed that AsiDNA decreased the frequency of telomere fusions without affecting the rate of telomere erosion. Further, it indicated that AsiDNA does not impact the choice of the repair pathway used for the fusion of short dysfunctional telomeres. AsiDNA is thought to prevent short telomeres from fusing by inhibiting DNA repair. An alternative, non-mutually exclusive possibility is that cells harbouring fusions preferentially die in the presence of AsiDNA, thus resulting in a reduction in fusion frequency. This important work could open the way for investigating the use of AsiDNA in the treatment of tumours that have short dysfunctional telomeres and/or are experiencing genomic instability.

摘要

端粒融合导致基因组不稳定,并被认为驱动克隆进化和肿瘤发生。端粒融合通过经典和替代非同源末端连接修复途径发生。AsiDNA 是一种 DNA 修复抑制剂,通过模拟 DNA 双链断裂 (DSB) 并劫持参与各种 DNA 修复途径的蛋白质的招募来发挥作用。在这项研究中,我们研究了 AsiDNA 通过抑制 DSB 修复途径是否可以防止危机期间的端粒融合。本研究表明,AsiDNA 降低了端粒融合的频率,而不影响端粒侵蚀的速度。此外,它表明 AsiDNA 并不影响用于融合短功能失调端粒的修复途径的选择。AsiDNA 被认为通过抑制 DNA 修复来防止短端粒融合。另一种非互斥的可能性是,在 AsiDNA 存在的情况下,融合的细胞更倾向于死亡,从而导致融合频率降低。这项重要的工作为研究 AsiDNA 在治疗具有短功能失调端粒和/或经历基因组不稳定的肿瘤中的应用开辟了道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2973/8091035/26caaf7c500a/ddab008f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2973/8091035/f3e907578eed/ddab008f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2973/8091035/eddd4319cf32/ddab008f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2973/8091035/d4e90ad2533f/ddab008f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2973/8091035/86226d5e60f2/ddab008f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2973/8091035/26caaf7c500a/ddab008f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2973/8091035/f3e907578eed/ddab008f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2973/8091035/eddd4319cf32/ddab008f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2973/8091035/d4e90ad2533f/ddab008f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2973/8091035/86226d5e60f2/ddab008f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2973/8091035/26caaf7c500a/ddab008f5.jpg

相似文献

1
Effect of DNA repair inhibitor AsiDNA on the incidence of telomere fusion in crisis. AsiDNA 对危机中端粒融合发生率的影响。
Hum Mol Genet. 2021 Apr 26;30(3-4):172-181. doi: 10.1093/hmg/ddab008.
2
Both the classical and alternative non-homologous end joining pathways contribute to the fusion of drastically shortened telomeres induced by TRF2 overexpression.经典和替代性非同源末端连接途径均有助于因 TRF2 过表达而导致的严重缩短端粒的融合。
Cell Cycle. 2019 Apr;18(8):880-888. doi: 10.1080/15384101.2019.1598724. Epub 2019 Apr 6.
3
Inhibition of DNA Repair by Inappropriate Activation of ATM, PARP, and DNA-PK with the Drug Agonist AsiDNA.药物激动剂 AsiDNA 引起 ATM、PARP 和 DNA-PK 的异常激活抑制 DNA 修复。
Cells. 2022 Jul 8;11(14):2149. doi: 10.3390/cells11142149.
4
Dysfunctional mammalian telomeres join with DNA double-strand breaks.功能失调的哺乳动物端粒与DNA双链断裂相连。
DNA Repair (Amst). 2004 Apr 1;3(4):349-57. doi: 10.1016/j.dnarep.2003.11.007.
5
Escape from telomere-driven crisis is DNA ligase III dependent.逃离端粒驱动的危机依赖于DNA连接酶III。
Cell Rep. 2014 Aug 21;8(4):1063-76. doi: 10.1016/j.celrep.2014.07.007. Epub 2014 Aug 7.
6
Preclinical Studies Comparing Efficacy and Toxicity of DNA Repair Inhibitors, Olaparib, and AsiDNA, in the Treatment of Carboplatin-Resistant Tumors.比较DNA修复抑制剂、奥拉帕尼和AsiDNA在治疗铂类耐药肿瘤中的疗效和毒性的临床前研究。
Front Oncol. 2019 Nov 12;9:1097. doi: 10.3389/fonc.2019.01097. eCollection 2019.
7
Micronuclei Frequency in Tumors Is a Predictive Biomarker for Genetic Instability and Sensitivity to the DNA Repair Inhibitor AsiDNA.肿瘤中的微核频率是遗传不稳定性和对 DNA 修复抑制剂 AsiDNA 敏感性的预测性生物标志物。
Cancer Res. 2017 Aug 15;77(16):4207-4216. doi: 10.1158/0008-5472.CAN-16-2693. Epub 2017 Jun 6.
8
The role of double-strand break repair pathways at functional and dysfunctional telomeres.双链断裂修复途径在功能性和功能失调性端粒中的作用。
Cold Spring Harb Perspect Biol. 2014 Sep 16;6(12):a016576. doi: 10.1101/cshperspect.a016576.
9
Histone depletion prevents telomere fusions in pre-senescent cells.组蛋白耗竭可防止衰老前期细胞中的端粒融合。
PLoS Genet. 2018 Jun 7;14(6):e1007407. doi: 10.1371/journal.pgen.1007407. eCollection 2018 Jun.
10
Mitosis, double strand break repair, and telomeres: a view from the end: how telomeres and the DNA damage response cooperate during mitosis to maintain genome stability.有丝分裂、双链断裂修复与端粒:从末端看:端粒与DNA损伤反应在有丝分裂过程中如何协作以维持基因组稳定性。
Bioessays. 2014 Nov;36(11):1054-61. doi: 10.1002/bies.201400104. Epub 2014 Aug 29.

引用本文的文献

1
Telomere-related DNA damage response pathways in cancer therapy: prospective targets.癌症治疗中与端粒相关的DNA损伤反应途径:潜在靶点
Front Pharmacol. 2024 Jun 7;15:1379166. doi: 10.3389/fphar.2024.1379166. eCollection 2024.
2
Inhibition of DNA Repair by Inappropriate Activation of ATM, PARP, and DNA-PK with the Drug Agonist AsiDNA.药物激动剂 AsiDNA 引起 ATM、PARP 和 DNA-PK 的异常激活抑制 DNA 修复。
Cells. 2022 Jul 8;11(14):2149. doi: 10.3390/cells11142149.

本文引用的文献

1
DNA polymerase theta (Polθ) - an error-prone polymerase necessary for genome stability.DNA 聚合酶 θ(Polθ)- 一种易错聚合酶,对于基因组稳定性是必需的。
Curr Opin Genet Dev. 2020 Feb;60:119-126. doi: 10.1016/j.gde.2020.02.017. Epub 2020 Apr 14.
2
Genome rearrangements associated with aberrant telomere maintenance.与异常端粒维持相关的基因组重排。
Curr Opin Genet Dev. 2020 Feb;60:31-40. doi: 10.1016/j.gde.2020.02.005. Epub 2020 Mar 4.
3
Preclinical Studies Comparing Efficacy and Toxicity of DNA Repair Inhibitors, Olaparib, and AsiDNA, in the Treatment of Carboplatin-Resistant Tumors.
比较DNA修复抑制剂、奥拉帕尼和AsiDNA在治疗铂类耐药肿瘤中的疗效和毒性的临床前研究。
Front Oncol. 2019 Nov 12;9:1097. doi: 10.3389/fonc.2019.01097. eCollection 2019.
4
Combining the DNA Repair Inhibitor Dbait With Radiotherapy for the Treatment of High Grade Glioma: Efficacy and Protein Biomarkers of Resistance in Preclinical Models.将DNA修复抑制剂Dbait与放射疗法联合用于治疗高级别胶质瘤:临床前模型中的疗效和抗性蛋白生物标志物
Front Oncol. 2019 Jun 19;9:549. doi: 10.3389/fonc.2019.00549. eCollection 2019.
5
Telomere length predicts for outcome to FCR chemotherapy in CLL.端粒长度可预测 CLL 患者对 FCR 化疗的反应。
Leukemia. 2019 Aug;33(8):1953-1963. doi: 10.1038/s41375-019-0389-9. Epub 2019 Jan 30.
6
PARP1 is required for preserving telomeric integrity but is dispensable for A-NHEJ.聚(ADP-核糖)聚合酶1(PARP1)是维持端粒完整性所必需的,但对于非同源末端连接(A-NHEJ)则并非必需。
Oncotarget. 2018 Oct 5;9(78):34821-34837. doi: 10.18632/oncotarget.26201.
7
The DNA Repair Inhibitor Dbait Is Specific for Malignant Hematologic Cells in Blood.DNA 修复抑制剂 Dbait 特异性杀伤血液中的恶性血液病细胞。
Mol Cancer Ther. 2017 Dec;16(12):2817-2827. doi: 10.1158/1535-7163.MCT-17-0405. Epub 2017 Sep 25.
8
Micronuclei Frequency in Tumors Is a Predictive Biomarker for Genetic Instability and Sensitivity to the DNA Repair Inhibitor AsiDNA.肿瘤中的微核频率是遗传不稳定性和对 DNA 修复抑制剂 AsiDNA 敏感性的预测性生物标志物。
Cancer Res. 2017 Aug 15;77(16):4207-4216. doi: 10.1158/0008-5472.CAN-16-2693. Epub 2017 Jun 6.
9
Extensive telomere erosion is consistent with localised clonal expansions in Barrett's metaplasia.广泛的端粒侵蚀与巴雷特化生中的局部克隆性扩张一致。
PLoS One. 2017 Mar 31;12(3):e0174833. doi: 10.1371/journal.pone.0174833. eCollection 2017.
10
Telomere length is a critical determinant for survival in multiple myeloma.端粒长度是多发性骨髓瘤生存的关键决定因素。
Br J Haematol. 2017 Jul;178(1):94-98. doi: 10.1111/bjh.14643. Epub 2017 Mar 24.